Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases

Aim. To determine whether the serum level of NGAL can discriminate cholangiocarcinoma from benign biliary tract disease in patients. Methods. This study was performed according to a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design. A total of 50 cholangiocarcinoma and...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Leelawat, Kawin, Narong, Siriluck, Wannaprasert, Jerasak, Leelawat, Surang
Formáid: Artigo
Teanga:Inglês
Foilsithe: SAGE-Hindawi Access to Research 2011
Ábhair:
Clinical Study
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3170848/
https://ncbi.nlm.nih.gov/pubmed/21994874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/873548
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla